| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.1B | $0.1B | $-0.1B | $0.0B | $0.0B | $0.0B | $-0.0B |
| EPS (Basic) | $0.90 | $1.23 | $1.68 | $-3.12 | $0.33 | $1.16 | $0.90 | $-1.45 |
| EPS (Diluted) | $0.90 | $1.23 | $1.68 | $-3.12 | $0.33 | $1.16 | $0.90 | $-1.45 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.7B | $6.9B | $6.1B | $4.4B | $3.4B | $1.4B | $4.3B | $3.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.0B |
| Total Liabilities | $8.2B | $6.4B | $5.6B | $3.9B | $2.8B | $1.0B | $3.5B | $2.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.6B | $0.5B | $0.5B | $0.5B | $0.6B | $0.4B | $0.8B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B |
| Investing Cash Flow | $-1.7B | $-0.7B | $-0.4B | $-1.5B | $-1.9B | $2.2B | $-0.7B | $0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $1.5B | $0.7B | $0.4B | $1.5B | $1.9B | $-2.3B | $0.7B | $-0.2B |